Evaluation of protocol amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) study during the COVID-19 pandemic.

MLA

Penno, Megan A. S., et al. “Evaluation of Protocol Amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) Study during the COVID-19 Pandemic.” Diabetic Medicine : A Journal of the British Diabetic Association, vol. 38, no. 11, Nov. 2021, p. e14638. EBSCOhost, https://doi.org/10.1111/dme.14638.

APA

Penno, M. A. S., Anderson, A. J., Thomson, R. L., McGorm, K., Barry, S. C., Colman, P. G., Craig, M. E., Davis, E. A., Harris, M., Haynes, A., Morahan, G., Oakey, H., Rawlinson, W. D., Sinnott, R. O., Soldatos, G., Vuillermin, P. J., Wentworth, J. M., Harrison, L. C., & Couper, J. J. (2021). Evaluation of protocol amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) study during the COVID-19 pandemic. Diabetic Medicine : A Journal of the British Diabetic Association, 38(11), e14638. https://doi.org/10.1111/dme.14638

Chicago

Penno, Megan A S, Amanda J Anderson, Rebecca L Thomson, Kelly McGorm, Simon C Barry, Peter G Colman, Maria E Craig, et al. 2021. “Evaluation of Protocol Amendments to the Environmental Determinants of Islet Autoimmunity (ENDIA) Study during the COVID-19 Pandemic.” Diabetic Medicine : A Journal of the British Diabetic Association 38 (11): e14638. doi:10.1111/dme.14638.